President Donald Trump has long proposed cutting Medicaid, which covers healthcare for lower-income Americans.
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
Analyst David Windley of Jefferies maintained a Buy rating on UnitedHealth (UNH – Research Report), reducing the price target to $609.00.Invest ...
TD Cowen analyst Ryan Langston maintained a Buy rating on UnitedHealth (UNH – Research Report) yesterday and set a price target of ...
The company has developed technology that uses patients’ smartphones to deliver data and insights to clinicians and payers.
In 2024, a ransomware attack on Change Healthcare — a health payment processing company that handles an estimated 15 billion medical claims annually — shook the health care industry, impacting medical ...
Eight of the 30 Dow components lost value in 2024. Here's a quick look at each company, to help you determine which dividend ...
A D.C. health care research firm led by an Advisory Board alum has landed an investment from a big-name backer to build up its user base and make a name for itself in the industry.
UnitedHealth's OptumRx to pass 100% of drug rebates to clients by 2028, but critics say GPO structure may still hide true ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback